In fact, estrogen deficiency predisposes post-menopausal women to dysglycemia and to impaired hepatic insulin clearance, which can be improved by estrogen administration, thus reducing the risk of developing T2D [128,129,130]. The gene discussed is INS; the disease is type 2 diabetes mellitus.